Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Lexicon Pharmaceuticals, Inc. (LXRX) had Return on Investments of -0.41% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$21.10M |
|
$-1.04M |
|
$0.11M |
|
$20.99M |
|
$22.10M |
|
$-1.00M |
|
$-0.05M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.00M |
|
$-0.20M |
|
400.24M |
|
400.24M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$186.03M |
|
$1.75M |
|
$82.79M |
|
$268.82M |
|
$9.90M |
|
$49.68M |
|
$56.06M |
|
$65.96M |
|
$202.85M |
|
$158.31M |
|
$202.86M |
|
423.77M |
|
| Cash Flow Statement Financials | |
$-14.73M |
|
$-70.26M |
|
$88.76M |
|
$63.33M |
|
$67.09M |
|
$3.76M |
|
$3.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.79 |
|
-- |
|
-- |
|
0.20 |
|
0.24 |
|
99.49% |
|
-4.72% |
|
-4.72% |
|
-- |
|
-4.94% |
|
-4.94% |
|
$-14.73M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.39 |
|
1.79 |
|
50.24 |
|
-0.51% |
|
-0.66% |
|
-0.39% |
|
|
Return on Investments |
-0.41% |
$0.48 |
|
$-0.04 |
|
$-0.04 |
|